102 – 4475 Wayburne Drive
Member Sector: Biopharmaceuticals
Symvivo is a biotechnology company in the cancer gene therapy field. We have developed a novel bacterial based gene delivery platform technology for the treatment of solid tumors. This approach has the potential to integrate with and improve existing therapies where treatment options are currently limited.